Lonza Announces Settlements in Patent Infringement Suits 30063

February 2, 2004

1 Min Read
Supply Side Supplement Journal logo in a gray background | Supply Side Supplement Journal


Lonza Announces Settlements in Patent Infringement Suits

FAIR LAWN, N.J.Lonza Inc. (www.lonza.com),a subsidiary of Basel, Switzerland-based Lonza Group Ltd., announced settlementof two patent infringement actions filed in late 2002. Under terms of the Jan. 8settlements, Axel Chemicals LLC and Stauber Performance Ingredients Inc. agreedto refrain from future infringement; Lonzas action concerned U.S. Patent No.5,073,376, which covers solid oral dosage forms, including tablets and capsules,of L-carnitine L-tartrate for human consumption. Azel and Stauber also agreed topay undisclosed sums for past infringement of Lonzas patent rights.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like